Dividend-adjusted total return · Nov 11, 2021 – Nov 5, 2026GDOC
Goldman Sachs Future Health Care Equity ETFGDOC
$38.47
−3.1% last session
+8.4% YTD
Data as of 11/5/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −3.1% | +5.8% | +4.2% | +8.4% | +12.0% | +38.8% | — | −0.6% |
| Peer average | −2.3% | −4.4% | −6.6% | +1.6% | +6.3% | +97.4% | +85.8% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $20M
- Expense ratio
- 0.75%
- Distribution yield
- 0.3%
- NAV
- $38.64
- Volume
- 311
- Avg. volume 30D
- 425
- High today
- $39.11
- Low today
- $38.47
- Previous close
- $39.69
- 52-week high
- $39.70
- 52-week low
- $31.32
- Our risk indicator
- 4/5
GDOC in One Breath
GDOC Among Gold ETFs
YTDEnd-of-day Nov 6, 2026 · 41 Gold ETFs by YTD
$10,000 in GDOC
5Y$10,000 in GDOC became
$9,943
In the S&P 500 (VOO)
$16,955
Total return, dividends in · Nov 11, 2021 – Nov 5, 2026 · S&P 500 uses VOO
GDOC’s Top Holdings
TodayLLYEli Lilly &14.1%JNJ6.0%UNH5.7%MRK4.9%EW4.1%VRTX4.0%A3.8%TMO3.8%GH3.6%DXCM3.5%GILD3.1%AZN.L3.1%LONN.SW3.0%ABBV3.0%ISRG2.8%VEEV2.8%COR2.8%ROIV2.6%MTD2.0%RPRX1.8%INSM1.5%18 more
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsOther
Goldman Sachs GDOC · 40 holdings · tile size = share of the fund · as of Nov 5, 2026
What GDOC Holds
TodayDrug Manufacturers - General34.2%
LLY 14.1 · JNJ 6.0 · MRK 4.9 · GILD 3.1 · AZN.L 3.1 · ABBV 3.0
Biotechnology20.0%
VRTX 4.0 · LONN.SW 3.0 · ROIV 2.6 · INSM 1.5 · CYTK 1.3 · BBIO 1.3 · TXG 1.2
Medical - Diagnostics & Research16.0%
A 3.8 · TMO 3.8 · GH 3.6 · MTD 2.0 · NTRA 1.5 · DGX 1.4
Medical - Devices9.0%
EW 4.1 · DXCM 3.5 · BSX 1.4
Medical - Healthcare Plans5.7%
UNH 5.7
Medical - Instruments & Supplies4.8%
ISRG 2.8 · RGEN 1.5 · DIM.PA
Software - Application2.8%
VEEV 2.8
Goldman Sachs GDOC · share of the fund by industry · as of Nov 5, 2026
Eli’s Share of GDOC
Today14.1%
$141 of every $1,000 in GDOC is Eli
Eli held by GDOC
$2.9M
Goldman Sachs GDOC · each square = $10 of $1,000 · as of Nov 5, 2026
GDOC’s Share of Gold ETFs
Today0.0%
of the $266B in 47 Gold ETFs
$20.3M0.0%
$131B49.3%
$59.9B22.5%
$75.1B28.2%
Gold ETF AUM · Nov 6, 2026
GDOC Fee per $100 vs Peers
TodayExpense ratio · Gold peers · Nov 6, 2026
Inside GDOC
40 holdings · as of Nov 5, 2026GDOC
Goldman Sachs Future Health Care Equity ETF
TodayDrug Manufacturers - General34.2%LLYELI Lilly &14.1%JNJ6.0%MRK4.9%GILD3.1%AZN.L3.1%ABBV3.0%Biotechnology20.0%VRTX4.0%LONN.SW3.0%ROIVINSMCYTKBBIOTXGARGXMDGLDNTHSYRERYTMKYMR3 moreMedical - Diagnostics16.0%A3.8%TMO3.8%GHMTDNTRADGXMedical - Devices9.0%EW4.1%DXCM3.5%BSXMedical - Healthcare Plans5.7%UNH5.7%Medical - Instruments4.8%ISRG2.8%RGENDIM.PSoftware - Application2.8%VEEVMedical - Distribution2.8%CORMedical - Pharmaceuticals1.8%RPRXGALD.S
Drug Manufacturers - General34.2%LLY14.1%JNJ6.0%MRK4.9%GILDAZN.LABBVBiotechnology20.0%VRTX4.0%LONN.SROIV2.6%INSMCYTK11 moreMedical - Diagnostics16.0%A3.8%TMOGHMTDNTRADGXMedical - Devices9.0%EWDXCM3.5%BSXMedical - Healthcare Plans5.7%UNHMedical - Instruments4.8%ISRGRGENSoftware - Application2.8%VEEVMedical - Distribution2.8%CORRPRXGALD.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.06% |
| 2 | JNJ | Johnson & Johnson | 6.03% |
| 3 | UNH | Unitedhealth Group Incorporated | 5.72% |
| 4 | MRK | Merck & | 4.92% |
| 5 | EW | Edwards Lifesciences | 4.11% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 3.98% |
| 7 | A | Agilent Technologies | 3.81% |
| 8 | TMO | Thermo Fisher Scientific | 3.78% |
| 9 | GH | Guardant Health | 3.57% |
| 10 | DXCM | Dexcom | 3.53% |
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsSoftware - ApplicationMedical - DistributionMedical - PharmaceuticalsDrug Manufacturers - SpecialtyOther
Goldman Sachs GDOC · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 80.4%
All GDOC Holdings
45 holdings · as of Nov 5, 2026GDOC
GDOC’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.06% | $1,406.27 | 2,066 | $2.9M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.03% | $603.25 | 4,548 | $1.3M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 5.72% | $572.25 | 2,912 | $1.2M |
| 4 | MRKMerck | Healthcare | 4.92% | $491.60 | 6,811 | $1.0M |
| 5 | EWEdwards Lifesciences | Healthcare | 4.11% | $411.27 | 8,622 | $857K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.98% | $398.23 | 1,511 | $830K |
| 7 | AAgilent Technologies | Healthcare | 3.81% | $381.43 | 4,485 | $795K |
| 8 | TMOThermo Fisher Scientific | Healthcare | 3.78% | $377.62 | 1,114 | $787K |
| 9 | GHGuardant Health | Healthcare | 3.57% | $356.95 | 4,411 | $744K |
| 10 | DXCMDexcom | Healthcare | 3.53% | $353.25 | 8,317 | $736K |
| 11 | GILDGilead Sciences | Healthcare | 3.15% | $314.58 | 3,756 | $655K |
| 12 | AZN.LAstrazeneca ORD | Healthcare | 3.11% | $310.52 | 3,424 | $647K |
| 13 | LONN.SWLonza Group AG | Healthcare | 3.00% | $299.65 | 771 | $624K |
| 14 | ABBVAbbvie | Healthcare | 2.97% | $297.35 | 2,101 | $619K |
| 15 | ISRGIntuitive Surgical | Healthcare | 2.77% | $277.24 | 1,198 | $578K |
Goldman Sachs GDOC · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
GDOC
Goldman Sachs Future Health Care Equity ETF’s Peers
YTDGold peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put GDOC head to head with GLD →GLD vs GDOC
YTDYear to date
GDOC wins+13.6 pts
Past year
GDOC wins+8.4 pts
Fee
GLD winslower fee
Yield
GDOC wins+0.3 pts
AUM
GLD6470.3× more
3–1GDOC wins
SPDR GLD and Goldman Sachs GDOC · year-to-date · as of Nov 6, 2026 · AUM not scored
GDOC vs VOO
YTDGDOC · Goldman Sachs Future Health Care Equity
+8.4%
VOO · S&P 500
+8.4%
Gap
0.0 pts
Goldman Sachs GDOC and Vanguard VOO · YTD total return · as of Nov 6, 2026
GDOC vs Its Peer Average
YTDGDOCAvsBPeer average
1D−3.1%−2.3%
1M+5.8%−4.4%
3M+4.2%−6.6%
YTD+8.4%+1.6%
1Y+12.0%+6.3%
3Y+38.8%+97.4%
5Y[…]+85.8%
4–2GDOC wins
46 Gold peers · each row scaled to its leader
The Details
GDOC
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.99%
Deepest drop · 1Y−15.7%
Lowest point · 5Y−26.9%
52-week range
$38.47
$31.32−3.1% from the high$39.70
Goldman Sachs GDOC · past-year price moves · as of Nov 6, 2026
GDOC
Fund Facts
Today2021launched Nov 9
Tracks[…]
Exchange · CUSIPAMEX · 38149W770
StructureETF
Leverage1x
Cost on $10,000$75 a year
Go deeper
Goldman Sachs GDOC · fund facts · as of Nov 6, 2026
GDOC
Payouts by Year
4Y$0.11per share, Dec 2025
Distribution yield0.3%
PaidOnce a year
Latest ex-date · paidDec 23 · Dec 30, 2025
4 payouts added up$0.30 a share
Goldman Sachs GDOC · distributions by ex-date · 2022–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2026-02-28 ↗SEC reported portfolio · 2025-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗
Trading & Liquidity
Net asset value$38.64
Premium / discount[…]
Median spread · 30D[…]
Volume today311
Average volume · 30D425
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.75%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$75.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |
Issuer contentFrom Goldman SachsHear the strategy from the people behind GDOC.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →